551 related articles for article (PubMed ID: 19371738)
21. Evaluation of the effect of ethanol's toxic metabolite acetaldehyde on the gastrointestinal oligopeptide transporter, PEPT1: in vitro and in vivo studies.
Fisher SJ; Lee IJ; Swaan PW; Eddington ND
Alcohol Clin Exp Res; 2008 Jan; 32(1):162-70. PubMed ID: 18028524
[TBL] [Abstract][Full Text] [Related]
22. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
Thomsen AE; Christensen MS; Bagger MA; Steffansen B
Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
[TBL] [Abstract][Full Text] [Related]
23. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
[TBL] [Abstract][Full Text] [Related]
24. High-affinity interaction of sartans with H+/peptide transporters.
Knütter I; Kottra G; Fischer W; Daniel H; Brandsch M
Drug Metab Dispos; 2009 Jan; 37(1):143-9. PubMed ID: 18824524
[TBL] [Abstract][Full Text] [Related]
25. Effects of JBP485 on the expression and function of PEPT1 in indomethacin-induced intestinal injury in rats and damage in Caco-2 cells.
Wang W; Liu Q; Wang C; Meng Q; Kaku T; Liu K
Peptides; 2011 May; 32(5):946-55. PubMed ID: 21310202
[TBL] [Abstract][Full Text] [Related]
26. Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter.
Lafforgue G; Arellano C; Vachoux C; Woodley J; Philibert C; Dupouy V; Bousquet-Mélou A; Gandia P; Houin G
Fundam Clin Pharmacol; 2008 Apr; 22(2):189-201. PubMed ID: 18353114
[TBL] [Abstract][Full Text] [Related]
27. Quantitative prediction of oral absorption of PEPT1 substrates based on in vitro uptake into Caco-2 cells.
Shimizu R; Sukegawa T; Tsuda Y; Itoh T
Int J Pharm; 2008 Apr; 354(1-2):104-10. PubMed ID: 18276092
[TBL] [Abstract][Full Text] [Related]
28. Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080.
Nakanishi T; Tamai I; Sai Y; Sasaki T; Tsuji A
Cancer Res; 1997 Sep; 57(18):4118-22. PubMed ID: 9307302
[TBL] [Abstract][Full Text] [Related]
29. Characterization of stably transfected kidney epithelial cell line expressing rat H+/peptide cotransporter PEPT1: localization of PEPT1 and transport of beta-lactam antibiotics.
Terada T; Saito H; Mukai M; Inui K
J Pharmacol Exp Ther; 1997 Jun; 281(3):1415-21. PubMed ID: 9190878
[TBL] [Abstract][Full Text] [Related]
30. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells.
Wenzel U; Gebert I; Weintraut H; Weber WM; Clauss W; Daniel H
J Pharmacol Exp Ther; 1996 May; 277(2):831-9. PubMed ID: 8627565
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a thiodipeptide, L-phenylalanyl-Ψ[CS-N]-L-alanine, as a novel probe for peptide transporter 1.
Arakawa H; Saito S; Kanagawa M; Kamioka H; Yano K; Morimoto K; Ogihara T
Drug Metab Pharmacokinet; 2014; 29(6):470-4. PubMed ID: 25008848
[TBL] [Abstract][Full Text] [Related]
32. alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line.
Berlioz F; Maoret JJ; Paris H; Laburthe M; Farinotti R; Rozé C
J Pharmacol Exp Ther; 2000 Aug; 294(2):466-72. PubMed ID: 10900220
[TBL] [Abstract][Full Text] [Related]
33. Diurnal rhythm of H+-peptide cotransporter in rat small intestine.
Pan X; Terada T; Irie M; Saito H; Inui K
Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G57-64. PubMed ID: 12065292
[TBL] [Abstract][Full Text] [Related]
34. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
[TBL] [Abstract][Full Text] [Related]
35. Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells.
Abe H; Satoh M; Miyauchi S; Shuto S; Matsuda A; Kamo N
Bioconjug Chem; 1999; 10(1):24-31. PubMed ID: 9893960
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures.
Shu C; Shen H; Hopfer U; Smith DE
Drug Metab Dispos; 2001 Oct; 29(10):1307-15. PubMed ID: 11560874
[TBL] [Abstract][Full Text] [Related]
37. Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2.
Fujita T; Kishida T; Wada M; Okada N; Yamamoto A; Leibach FH; Ganapathy V
Brain Res; 2004 Jan; 997(1):52-61. PubMed ID: 14715149
[TBL] [Abstract][Full Text] [Related]
38. Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2.
Irie M; Terada T; Okuda M; Inui K
Pflugers Arch; 2004 Nov; 449(2):186-94. PubMed ID: 15340850
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of mucosal glycylsarcosine uptake by acetate in rat distal small intestine.
Scharrer E; Amstutz I; Grenacher B
Exp Physiol; 1999 May; 84(3):541-8. PubMed ID: 10362852
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
Agarwal S; Jain R; Pal D; Mitra AK
Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
